Imprint Coding/Labeling

The WSMA strongly supports the imprinting of solid medication forms, generic or trademark prescription, including over-the-counter preparations. The WSMA also encourages improving the labeling of vials used in medical practice. (Res 35, C-87; Res 14, C-90) (Reaffirmed A-23)

The WSMA believes symbols and logotypes should not be used on drug imprint codes. (Res A-1, A-00) (Reaffirmed A-23)

Return to the WSMA Policy Compendium index

Abbreviations for House of Delegates report origination:

EC – Executive Committee; BT – Board of Trustees; CPA – Council on Professional Affairs; JC – Judicial Council; CHS – Community and Health Services